Literature DB >> 35942011

How to Optimize Rosacea Treatment for Better Patient Outcomes: An Opinion Piece.

Martin Schaller1, Jerry Tan2, Guy Webster3.   

Abstract

Rosacea is a chronic disease requiring long-term management. However, it is often treated according to package label instructions, which reflect the conditions of a Phase III study rather than a chronic disease. Furthermore, due to a lack of clinical data or guidelines on long-term treatment, many clinicians choose to discontinue treatment once success has been reached, rather than continuing with maintenance therapy. As experienced practicing dermatologists and investigators in the field, in this article we address the current evidence gaps in rosacea management and provide practical advice to clinicians on how optimal outcomes can be achieved and maintained in patients with rosacea in real-world practice, based on our own experience and the available clinical data.
Copyright © 2022. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Rosacea; best practice; chronic; maintenance; management; optimal; outcomes; treatment

Year:  2022        PMID: 35942011      PMCID: PMC9345196     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  19 in total

1.  Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

Authors:  James Q Del Rosso; Emil Tanghetti; Guy Webster; Linda Stein Gold; Diane Thiboutot; Richard L Gallo
Journal:  J Clin Aesthet Dermatol       Date:  2019-06-01

2.  Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.

Authors:  A Taieb; J P Ortonne; T Ruzicka; J Roszkiewicz; J Berth-Jones; M H Peirone; J Jacovella
Journal:  Br J Dermatol       Date:  2015-02-11       Impact factor: 9.302

3.  Face-to-face with anti-inflammatory therapy for rosacea.

Authors:  Suzanna Salzer; Thomas Ruzicka; Jürgen Schauber
Journal:  Exp Dermatol       Date:  2014-06       Impact factor: 3.960

4.  Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study.

Authors:  Angela Moore; Steven Kempers; George Murakawa; Jonathan Weiss; Amanda Tauscher; Leonard Swinyer; Hong Liu; Matthew Leoni
Journal:  J Drugs Dermatol       Date:  2014-01       Impact factor: 2.114

Review 5.  The rosacea patient journey: a novel approach to conceptualizing patient experiences.

Authors:  Sandy Kuo; Karen E Huang; Scott A Davis; Steven R Feldman
Journal:  Cutis       Date:  2015-01

6.  Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.

Authors:  Linda Stein Gold; Leon Kircik; Joseph Fowler; J Mark Jackson; Jerry Tan; Zoe Draelos; Alan Fleischer; Melanie Appell; Martin Steinhoff; Charles Lynde; Jeffrey Sugarman; Hong Liu; Jean Jacovella
Journal:  J Drugs Dermatol       Date:  2014-11       Impact factor: 2.114

Review 7.  Canadian Clinical Practice Guidelines for Rosacea.

Authors:  Yuka Asai; Jerry Tan; Akerke Baibergenova; Benjamin Barankin; Chris L Cochrane; Shannon Humphrey; Charles W Lynde; Danielle Marcoux; Yves Poulin; Jason K Rivers; Mariusz Sapijaszko; R Gary Sibbald; John Toole; Marcie Ulmer; Catherine Zip
Journal:  J Cutan Med Surg       Date:  2016-05-17       Impact factor: 2.092

8.  Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea.

Authors:  James Q Del Rosso; Guy F Webster; Mark Jackson; Marta Rendon; Phoebe Rich; Helen Torok; Mark Bradshaw
Journal:  J Am Acad Dermatol       Date:  2007-03-23       Impact factor: 11.527

9.  Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel.

Authors:  M Schaller; L M C Almeida; A Bewley; B Cribier; J Del Rosso; N C Dlova; R L Gallo; R D Granstein; G Kautz; M J Mannis; G Micali; H H Oon; M Rajagopalan; M Steinhoff; E Tanghetti; D Thiboutot; P Troielli; G Webster; M Zierhut; E J van Zuuren; J Tan
Journal:  Br J Dermatol       Date:  2019-10-16       Impact factor: 9.302

10.  A Tailored Approach to the Treatment of a Patient with a Severe Dynamic Manifestation of Rosacea: A Case Report.

Authors:  Martin Schaller; Lena Gonser
Journal:  Drugs R D       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.